Hepatitis Forums

Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on September 06, 2019, 10:29:07 am

Title: Experimental Vaccine Promotes T-Cell Activity Against Hepatitis B
Post by: Hep Editors on September 06, 2019, 10:29:07 am

An experimental therapeutic vaccine known as GS-4774, used in combination with Viread (tenofovir disoproxil fumarate), increased the activity of T cells that target hepatitis B virus (HBV), according to Phase II study results reported in the journal Gastroenterology.

Although the vaccine did not reduce levels of hepatitis B surface antigen (HBsAg)—considered an indicator of a cure—the researchers suggested that GS-4774 might be useful as a component of combination therapy for chronic hepatitis B.

For more...
https://www.hepmag.com/article/experimental-vaccine-promotes-tcell-activity-hepatitis-b